Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can New Imaging- and Biomarkers Improve the Assessment of Disease Activity and Progression and Predict Therapeutic Outcome in Psoriatic Arthritis Patients Receiving Adalimumab?

NCT01465438 is registered in ClinicalTrials.gov with Glostrup University Hospital, Copenhagen as lead sponsor.

NCT NCT01465438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01465438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can New Imaging- and Biomarkers Improve the Assessment of Disease Activity and Progression and Predict Therapeutic Outcome in Psoriatic Arthritis Patients Receiving Adalimumab?
Lead sponsor
Glostrup University Hospital, Copenhagen
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2006
Completion date
June 30, 2011
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis